Alhemo Injection, Solution
Product Images NDC 0169-2080

Product Visual Gallery

This gallery contains 40 technical images submitted to the FDA as part of the official labeling for Alhemo (NDC 0169-2080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-pen.jpg (100mg Pen)

An exploded view diagram of the Alhemo injection pen for concizumab, showing labeled parts including the pen cap, pen scale, pen window, pen label, dose counter, dose pointer, dose selector, and dose button. An example needle assembly with outer needle cap, inner needle cap, needle, and paper tab is also depicted alongside the pen.*

FDA Label Image

300mg-pen.jpg (300mg Pen)

An instructional diagram showing the components of an Alhemo injection pen for subcutaneous use. Labeled parts include the pen cap, pen scale with window, pen label, dose counter and pointer, dose selector and button, along with a needle assembly consisting of an outer needle cap, inner needle cap, needle, and a paper tab.*

FDA Label Image

5a-figure-300.jpg (5 A Figure 300)

Instructional illustration showing how to administer an injection at a 90-degree angle to the skin. The image depicts a hand holding an injection pen perpendicular to the arm, indicating subcutaneous injection technique.*

FDA Label Image

5b-figure-300.jpg (5 B Figure 300)

An instructional illustration showing a hand holding an injection pen device for subcutaneous administration. The illustration includes text prompting the user to count slowly "1-2-3-4-5-6" during injection, likely to guide timing for proper delivery of the medication.*

FDA Label Image

5a-figure-100mg.jpg (5a Figure)

An instructional diagram showing a hand holding an injection device, positioned at a 90-degree angle to the skin, illustrating proper subcutaneous injection technique. The image highlights correct placement and angle for administering the injection of Alhemo (concizumab) injection solution.*

FDA Label Image

60mg-1.5ml.jpg (60mg 1.5ml.jpg)

Illustration showing a labeled view of the Alhemo injection pen for subcutaneous administration. Components identified include pen cap, pen scale, pen window, pen label, dose counter, dose pointer, dose selector, and dose button. Additionally, needle components are shown: outer needle cap, inner needle cap, needle, and a paper tab.*

FDA Label Image

Carton-150mg.jpg (Carton 150mg)

Packaging label for Alhemo (concizumab-mtci) injection, 150 mg/1.5 mL (100 mg/mL), a subcutaneous injection by Novo Nordisk. The label indicates a single-user prefilled pen containing 150 mg total in 1.5 mL, with dosing in 1 mg increments. The design features the product name, strength, usage instructions, barcode, and an image of the prefilled pen on a gold and white dotted background.*

FDA Label Image

Carton-300mg.jpg (Carton 300mg)

Alhemo (concizumab-mtci) injection 300 mg/3 mL (100 mg/mL) is shown in its packaging label. It is a subcutaneous injection supplied in a single-patient-use prefilled pen containing 3 mL total volume. The label includes dosage information, manufacturer Novo Nordisk details, a barcode, and images of the injection pen.*

FDA Label Image

Carton-60mg.jpg (Carton 60mg)

Alhemo (concizumab-mtci) injection, 60 mg/1.5 mL (40 mg/mL), is displayed on a brown carton label with white and blue text. The label shows a depiction of a prefilled subcutaneous injection pen, manufactured by Novo Nordisk. The packaging indicates single-patient use, available in 1x1.5 mL prefilled pen form, with dosing increments of 0.4 mg. The label includes usage instructions and regulatory details.*

FDA Label Image

Example-13-left-60mg.jpg (Example 13 Left)

An instructional illustration showing a hand holding an injection pen for Alhemo (concizumab) subcutaneous injection. The pen's dose window displays the remaining amount of medication, with an example reading of 13.6 mg left.*

FDA Label Image

Example-200mg-300.jpg (Example 200mg 300)

An instructional diagram showing an example measurement on a syringe for Alhemo concizumab injection. It illustrates a syringe with a liquid level corresponding to 200 mg remaining, likely indicating dose measurement or remaining medication volume.*

FDA Label Image

Example-24-15-100mg.jpg (Example 24 15mg)

An instructional illustration showing the Alhemo injection device labeled with the brand name and dosage display windows indicating example doses of 24 mg and 15 mg. The image depicts a hand holding the device, demonstrating how to read the dose from the window and the device's design for subcutaneous injection.*

FDA Label Image

Example-24mg-left-60mg.jpg (Example 24mg Left)

An instructional diagram showing a measuring scale on a syringe or injection device marked with volumes 12, 24, and 36 mL. An example text '24 mg left' is displayed, likely illustrating how to read the remaining medication volume.*

FDA Label Image

Example-24-15-300mg.jpg (Example 34 15 300mg)

Illustration shows an Alhemo (concizumab) subcutaneous injection pen with a dosage window displaying 24 mg. The image includes examples of dosage windows showing 24 mg and 15 mg and depicts the pen being held and prepared for dosing.*

FDA Label Image

Example-34mg-300.jpg (Example 34mg 300)

An instructional illustration showing a hand holding a dose counter, indicating a remaining dose example of 34 mg left. The image visually demonstrates how to read the remaining medication amount on a dosing device, relevant for products like Alhemo injection solution.*

FDA Label Image

Example-34mg.jpg (Example 34mg)

An instructional illustration showing a hand holding an injection pen for Alhemo concizumab subcutaneous injection. A small digital display on the device indicates the remaining dose example of 34 mg left.*

FDA Label Image

Example-60-100mg.jpg (Example 60mg)

An instructional illustration showing an example of "60 mg left" indicated by a liquid level marking on a small injection device or syringe. The image depicts a partially filled injectable solution container used likely for dose measurement guidance.*

FDA Label Image

Example-9-60mg.jpg (Example 9)

An instructional illustration showing the Alhemo injection pen device held in a hand for subcutaneous use. Insets zoom in on the dosage window, displaying examples of 9.6 mg and 12 mg dose settings visible on the dose indicator. The pen is labeled with the proprietary name Alhemo.*

FDA Label Image

Figure-5-a-60mg.jpg (Figure 5 A)

Illustration demonstrating the correct injection technique for Alhemo (concizumab) injection solution. It shows a hand holding the injection device and inserting it subcutaneously at a 90-degree angle to the skin. An arrow indicates the direction of injection toward the skin fold.*

FDA Label Image

Figure-5-b-100mg.jpg (Figure 5 B 01)

An instructional illustration showing how to hold the Alhemo (concizumab) injection pen for subcutaneous administration. The image depicts a hand gripping the injection device, accompanied by a prompt to count slowly from 1 to 6 during the injection process.*

FDA Label Image

Figure-5-b-60mg.jpg (Figure 5 B)

An instructional illustration showing a hand holding an injection pen labeled Alhemo (concizumab) against a forearm. A speech bubble instructs to count slowly from one to six, indicating timing during subcutaneous injection.*

FDA Label Image

Figure-6-300.jpg (Figure 6 300)

An instructional diagram showing the needle tip and back end of the needle for an injection device. The image includes a close-up of a needle cap or cover and the top of a vial or container, illustrating how to attach or detach the needle from the device.*

FDA Label Image

Figure-6-100mg.jpg (Figure 6)

An instructional diagram showing the components of a needle assembly including the needle tip and back end of the needle. The diagram illustrates the connection process of the needle to a device, emphasizing the needle insertion direction with an arrow, and includes a close-up of the needle cap removal or placement.*

FDA Label Image

Figure-7-100mg.jpg (Figure 7)

Close-up image of a prefilled injection pen of Alhemo (concizumab) solution for subcutaneous injection. The visible portion shows a dark gray cap and part of the gold-colored pen body with a pattern of white dots. The labeler is Novo Nordisk and available strengths include 100 mg/mL and 40 mg/mL.*

FDA Label Image

Figure-a-b-300.jpg (Figure A B 300)

An instructional illustration showing two figures related to the Alhemo injection device. Figure A depicts a hand removing the outer needle cap by twisting it. Figure B shows components of the needle assembly including the needle, inner needle cap, and outer needle cap, indicating their order and removal direction with arrows.*

FDA Label Image

Figure-a-b-100mg.jpg (Figure A B)

An instructional diagram for the Alhemo injection device showing removal of the outer needle cap by hand (Figure A) and the needle with its inner and outer needle caps displayed separately with arrows indicating removal sequence (Figure B). This illustrates proper preparation steps for subcutaneous injection of concizumab.*

FDA Label Image

Figure-a-60mg (Figure A)

An instructional diagram showing a hand holding a subcutaneous injection pen of Alhemo (concizumab) and rotating the pen's needle cover to remove it. The image demonstrates the step of preparing the injection device before administration.*

FDA Label Image

Figure-b-60mg.jpg (Figure B)

An instructional diagram showing three components of an injection device labeled as Needle, Inner needle cap, and Outer needle cap with arrows indicating the sequence for assembly or removal. The image is part of the label for Alhemo (concizumab) injection by Novo Nordisk.*

FDA Label Image

Figure-c-d-100mg.jpg (Figure C D 01)

An instructional diagram showing the use of the Alhemo injection pen for subcutaneous administration. It depicts a hand holding the pen, adjusting the dosage to 1 mg, and demonstrates pressing the bottom of the pen to release the medication. The inset highlights the dosage selection dial indicating 1 mg.*

FDA Label Image

Figure-c-d-60mg.jpg (Figure C D)

An instructional diagram showing the use of the Alhemo injection, solution pen for subcutaneous administration. The illustration demonstrates the selection of a 0.4 mg dose on the dose selector window and the injection procedure with drops indicating subcutaneous delivery.*

FDA Label Image

Figure-d-c-300.jpg (Figure D C 300)

An instructional illustration showing the Alhemo injection pen by Novo Nordisk. The image demonstrates selecting a 1 mg dose on the pen's dial and the proper grip and injection technique with an arrow indicating pressing the pen tip against the skin for subcutaneous administration.*

FDA Label Image

Figure-step-6-60mg.jpg (Figure Step 6)

An instructional diagram showing the back end and needle tip of a needle attached to a brown injection device. An inset shows a close-up of a container with a removable cap, likely illustrating needle attachment or preparation for use.*

FDA Label Image

Figure-step-7-60mg.jpg (Figure Step 7)

The image shows a close-up of a single-dose injection pen needle cap in dark brown with a removable black protective cover. The cap has a white dot pattern near its base, commonly associated with needle caps for subcutaneous injections. No text or strength information is visible on the cap.*

FDA Label Image

Body-60mg.jpg (Image 11)

An anatomical illustration showing typical subcutaneous injection sites on a human body. Highlighted areas include the abdomen, upper outer thighs, and the back of the upper arms, indicating common areas for subcutaneous administration of injection solutions like concizumab (Alhemo).*

FDA Label Image

100-body.jpg (Image 20)

An anatomical illustration of a human figure highlighting typical subcutaneous injection sites on the abdomen and the front of the thighs. This diagram is likely provided to guide the administration of subcutaneous injection drugs such as Alhemo (concizumab).*

FDA Label Image

300-body.jpg (Image 30)

An anatomical illustration of a human body highlighting injection sites for subcutaneous administration on the abdomen and thighs. The image is likely related to the subcutaneous injection route for the drug Alhemo (concizumab).*

FDA Label Image

7-300-jpg (Image 36)

Alhemo concizumab injection, solution, subcutaneous, shown in a single-use pen device. This pen is intended for delivering the medication, with a black capsular cover and a lower section in yellow and black housing the injection mechanism. Labeler: Novo Nordisk.*

FDA Label Image

Qr-code-100mg.jpg (Qr Code 01)

FDA Label Image

Qr-code-300.jpg (Qr Code 300)

FDA Label Image

Qr-code-60mg.jpg (Qr Code)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.